Xtant Medical Holdings, Inc. (XTNT) Stock Price & Analysis
Xtant Medical Holdings, Inc. (XTNT) closed at USD 0.3 on Thursday, October 15, 2026, down 4.93% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0.32; the Oct 15, 2026 session ranged USD 0.3–0.33 on volume of 124,292 shares. Market capitalization is $42.48M, with a 52-week range of USD 0.27–0.95 (ASE). Source: Nexqual, retrieved October 16, 2026 at 05:21 UTC.
Also available as compact Markdown for AI agents: nexqual.com/XTNT.md
Key facts (XTNT)
- Analysts: Buy (mean 1.67 on a 1–5 scale) (3 analysts), mean target USD 1.03 (range 0.6–1.5).
- Total return with dividends: 1Y -57.8% vs S&P 500 +18.1%; 5Y -72.7% vs S&P 500 +85.1%.
- Next earnings: 2026-11-10, EPS estimate USD -0.02, revenue estimate $25.5M.
Analysts (XTNT)
Consensus Buy (mean 1.67 on a 1–5 scale), 3 analysts; mean target USD 1.03 (low 0.6, high 1.5).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-02 | LUCID CAPITAL MARKETS | Initiated | Buy | $1 |
Total return (dividends reinvested) (XTNT)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | -57.8% | -72.7% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -57.9% | -22.8% |
| Volatility (annualized) | 67.2% | 67.3% |
| Max drawdown | -67.4% (Oct 2025→Oct 2026) | -77.3% (Aug 2023→Oct 2026) |
Key Statistics (as of October 16, 2026 at 05:21 UTC)
| Price | USD 0.3 |
|---|---|
| Change | ▼ 4.93% (down) |
| Previous Close | USD 0.32 |
| Open | USD 0.31 |
| Day Range | USD 0.3 – 0.33 |
| 52-Week Range | USD 0.27 – 0.95 |
| Volume | 124,292 shares |
| Market Cap | $42.48M |
| Exchange | ASE |
Technical Analysis (XTNT)
Nexqual's technical model rates XTNT "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 16, 2026 at 05:21 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 31.87 (neutral) |
| vs SMA50 | Below (USD 0.35) |
| MACD | -0.01 (negative) |
Analyst Ratings (XTNT)
Wall Street analysts rate XTNT "Buy" based on 3 analysts, with a mean price target of USD 1.03 (range USD 0.6–1.5), per Nexqual as of October 16, 2026 at 05:21 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 1.03 |
| High Target | USD 1.5 |
| Low Target | USD 0.6 |
| Buy / Hold / Sell | 3 / 0 / 0 |
Earnings (XTNT)
| Next Earnings Date | 2026-11-10 |
|---|---|
| EPS Estimate | USD -0.02 |
| Revenue Estimate | $25.48M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.03 vs est -0.02 ▼ miss |
| 2026-03-31 | USD -0.02 vs est -0.02 ▲ beat |
| 2025-12-31 | USD -0.01 vs est 0 ▼ miss |
| 2025-09-30 | USD 0.01 vs est 0 ▲ beat |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financials & Fundamentals (XTNT)
| Total Revenue | $109.53M |
|---|---|
| Revenue Growth (latest quarter, YoY) | -35.00% |
| Gross Margin | +59.39% |
| Operating Margin | -18.10% |
| Profit Margin | -10.17% |
| ROE | -25.16% |
| Debt / Equity | 0.65 |
| Current Ratio | 2.16 |
| Total Cash | $9.87M |
| Total Debt | $26.01M |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financial Health Score (XTNT)
Nexqual rates Xtant Medical Holdings, Inc.'s overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:21 UTC.
| Growth | Solid — Revenue +14% YoY (annual) |
|---|---|
| Profitability | Mixed — Gross margin 59%, operating -18% |
| Balance Sheet | Strong — $10M cash vs $26M debt |
| Cash Flow | Solid — Operating cash flow $570K (TTM) |
| Efficiency | Critical — ROE -25%, ROA -3.8% |
Ownership (XTNT)
| Insider Ownership | +15.65% |
|---|---|
| Institutional Ownership | +56.94% |
| Shares Outstanding | 140.29M |
| Float | 54.18M |
| Short % of Float | +0.26% |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Leadership (XTNT)
Xtant Medical Holdings, Inc. is led by Sean E. Browne (age 59), President, CEO & Director, per Nexqual as of October 16, 2026 at 05:21 UTC.
| President, CEO & Director | Sean E. Browne (age 59) |
|---|---|
| Chief Financial Officer | Scott C. Neils (age 40) |
| Vice President of Human Resources | Catherine Lundy |
Major Backers & Investors (XTNT)
Notable institutional backers of Xtant Medical Holdings, Inc. include Nantahala Capital Management, LLC, AWM Investment Company, Inc., Renaissance Technologies, according to Nexqual as of October 16, 2026 at 05:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Nantahala Capital Management, LLC | 48.75% |
| AWM Investment Company, Inc. | 4.26% |
| Renaissance Technologies | 0.67% |
| Crescent Grove Advisors, Llc | 0.29% |
| Nano Cap New Millennium Growth Fund L P | 0.29% |
| Fidelity | 0.29% |
| Citadel | 0.14% |
| Acadian Asset Management. LLC | 0.13% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 3.06% |
| Geode Capital | 0.37% |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ESTA | Establishment Labs Holdings Inc | USD 61.36 | ▲ 4.98% |
| ALMR | Alamar Biosciences, Inc. | USD 27.42 | ▲ 16.58% |
| INSP | Inspire Medical Systems, Inc. | USD 70.12 | ▲ 1.83% |
| BFLY | Butterfly Network, Inc. | USD 7.85 | ▼ 3.09% |
| AXGN | AxoGen, Inc. | USD 35.63 | ▼ 1.49% |
| UFPT | UFP Technologies, Inc. | USD 297.19 | ▲ 0.99% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:21 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt